. The goal of this project is to define the proportion and characteristics of persons who should be vaccinated to control epidemic influenza.
The Specific Aims are to demonstrate that immunization of school-age and preschool children will reduce illness in vaccinated children and unvaccinated contacts in the same age cohort, in addition to household and community contacts, regardless of immunization status. Influenza epidemic periods will be defined by virologic surveillance. Medically attended illness rates will be compared for two defined populations, one with vaccinated school children and the other without. County-wide surveys will be performed to determine whether significant reductions of hospitalization rates for acute respiratory conditions accompany the vaccine program. Evaluation will include the level of acceptance of immunization with an intranasally administered vaccine, the accessibility of the target population, the time required for administration of the vaccine and the cost effect.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI041050-01
Application #
2005596
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1997-09-15
Project End
2002-08-31
Budget Start
1997-09-15
Budget End
1998-08-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Piedra, Pedro A; Gaglani, Manjusha J; Kozinetz, Claudia A et al. (2007) Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 120:e553-64
Smith, Catherine B; Cox, Nancy J; Subbarao, Kanta et al. (2002) Molecular epidemiology of influenza A(H3N2) virus reinfections. J Infect Dis 185:980-5